Detalhe da pesquisa
1.
Parents' responses to prognostic disclosure at diagnosis of a child with a high-risk brain tumor: Analysis of clinician-parent interactions and implications for clinical practice.
Pediatr Blood Cancer
; 68(3): e28802, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33226200
2.
A phase IIa trial of molecular radiotherapy with 177-lutetium DOTATATE in children with primary refractory or relapsed high-risk neuroblastoma.
Eur J Nucl Med Mol Imaging
; 47(10): 2348-2357, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32157433
3.
Immunohistochemical evaluation of molecular radiotherapy target expression in neuroblastoma tissue.
Eur J Nucl Med Mol Imaging
; 45(3): 402-411, 2018 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-29043399
4.
Clinical outcomes following proton therapy for children with central nervous system tumors referred overseas.
Pediatr Blood Cancer
; 64(12)2017 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-28544746
5.
Paediatric radiotherapy in the United Kingdom: an evolving subspecialty and a paradigm for integrated teamworking in oncology.
Br J Radiol
; 97(1153): 21-30, 2024 Jan 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-38263828
6.
Intensity-modulated arc therapy to improve radiation dose delivery in the treatment of abdominal neuroblastoma.
Future Oncol
; 9(3): 439-49, 2013 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-23469979
7.
Impact of cyclic changes in pharmacokinetics and absorbed dose in pediatric neuroblastoma patients receiving [177Lu]Lu-DOTATATE.
EJNMMI Phys
; 9(1): 24, 2022 Mar 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-35347483
8.
Renal protection during 177lutetium DOTATATE molecular radiotherapy in children: a proposal for safe amino acid infusional volume during peptide receptor radionuclide therapy.
Nucl Med Commun
; 43(2): 242-246, 2022 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34678829
9.
Localised rhabdomyosarcoma in infants (<12 months) and young children (12-36 months of age) treated on the EpSSG RMS 2005 study.
Eur J Cancer
; 160: 206-214, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34865946
10.
The spleen as an organ at risk in paediatric radiotherapy: A SIOP-Europe Radiation Oncology Working Group report.
Eur J Cancer
; 143: 1-10, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33271483
11.
68Ga-DOTATATE and 123I-mIBG as imaging biomarkers of disease localisation in metastatic neuroblastoma: implications for molecular radiotherapy.
Nucl Med Commun
; 41(11): 1169-1177, 2020 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-32796449
12.
Personalisation of Molecular Radiotherapy through Optimisation of Theragnostics.
J Pers Med
; 10(4)2020 Oct 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-33081161
13.
Adverse events of local treatment in long-term head and neck rhabdomyosarcoma survivors after external beam radiotherapy or AMORE treatment.
Eur J Cancer
; 51(11): 1424-34, 2015 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-25998323
14.
A systematic review of 131I-meta iodobenzylguanidine molecular radiotherapy for neuroblastoma.
Eur J Cancer
; 50(4): 801-15, 2014 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-24333097
15.
Results of a quality assurance review of external beam radiation therapy in the International Society of Paediatric Oncology (Europe) Neuroblastoma Group's High-risk Neuroblastoma Trial: a SIOPEN study.
Int J Radiat Oncol Biol Phys
; 85(1): 170-4, 2013 Jan 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-22749633
16.
177Lu-DOTATATE molecular radiotherapy for childhood neuroblastoma.
J Nucl Med
; 52(7): 1041-7, 2011 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-21680680